GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Valuation Rank

BLMH (Blum Holdings) Valuation Rank


View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Blum Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Blum Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Blum Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Valuation Rank
Comparable Companies
SCNX HKPD SSY RDGT HEWA SHWZ HKSE:06618 HKSE:00241 WBA TSE:3088 BSP:RADL3 JSE:CLS SHSE:603939 SAU:4164 TSE:3349 TSE:7649 TSE:9989 TSE:3391 TSE:3141 MEX:FRAGUAB
Traded in Other Exchanges
N/A
Address
3242 S. Halladay Street, Suite 202, Santa Ana, CA, USA, 92705
Website
https://www.blumholdings.com
Blum Holdings Inc is a cannabis company with operations in retail, production, distribution, and cultivation, with an emphasis on providing the highest quality of medical and adult-use cannabis products. It distributes its own branded products as well as third-party products to its retail dispensaries in California under the Korova brand. The company has two reportable segments; Cannabis Retail which generates key revenue and includes cannabis-focused retail, both physical stores and non-store front delivery, and the Cannabis Distribution segment which includes cannabis distribution operations.
Executives
Patty Chan officer: CHIEF FINANCIAL OFFICER 11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble officer: President 3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo director 1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum director 866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis director 11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass director 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson director, officer: President and CEO 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone other: Former Director of Issuer P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig officer: Chief Operating Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich director 2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner officer: Chief Financial Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez officer: Chief Financial Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan director, officer: Chief Executive Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614